110 related articles for article (PubMed ID: 34165425)
1. Comparison of the bactericidal effects of quinolones against low-susceptible
Mizoi K; Wajima T; Tanaka E; Nakaminami H; Noguchi N
J Med Microbiol; 2021 Jun; 70(6):. PubMed ID: 34165425
[TBL] [Abstract][Full Text] [Related]
2. Emergence of Haemophilus influenzae with low susceptibility to quinolones and persistence in tosufloxacin treatment.
Tanaka E; Hara N; Wajima T; Ochiai S; Seyama S; Shirai A; Shibata M; Shiro H; Natsume Y; Noguchi N
J Glob Antimicrob Resist; 2019 Sep; 18():104-108. PubMed ID: 30753907
[TBL] [Abstract][Full Text] [Related]
3. Earlier generation quinolones can be useful in identifying Haemophilus influenzae strains with low susceptibility to quinolone isolated from paediatric patients.
Tanaka E; Wajima T; Noguchi N
J Med Microbiol; 2019 Aug; 68(8):1227-1232. PubMed ID: 31215858
[TBL] [Abstract][Full Text] [Related]
4. Activities and postantibiotic effects of gemifloxacin compared to those of 11 other agents against Haemophilus influenzae and Moraxella catarrhalis.
Davies TA; Kelly LM; Hoellman DB; Ednie LM; Clark CL; Bajaksouzian S; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 2000 Mar; 44(3):633-9. PubMed ID: 10681330
[TBL] [Abstract][Full Text] [Related]
5. Dissemination of quinolone low-susceptible Haemophilus influenzae ST422 in Tokyo, Japan.
Tanaka E; Wajima T; Hirai Y; Nakaminami H; Noguchi N
J Infect Chemother; 2021 Jul; 27(7):962-966. PubMed ID: 33612378
[TBL] [Abstract][Full Text] [Related]
6. A molecular analysis of quinolone-resistant Haemophilus influenzae: validation of the mutations in Quinolone Resistance-Determining Regions.
Shoji H; Shirakura T; Fukuchi K; Takuma T; Hanaki H; Tanaka K; Niki Y
J Infect Chemother; 2014 Apr; 20(4):250-5. PubMed ID: 24480551
[TBL] [Abstract][Full Text] [Related]
7. Mutant selection window of four quinolone antibiotics against clinical isolates of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis.
Nakai H; Sato T; Uno T; Furukawa E; Kawamura M; Takahashi H; Watanabe A; Fujimura S
J Infect Chemother; 2018 Feb; 24(2):83-87. PubMed ID: 29290527
[TBL] [Abstract][Full Text] [Related]
8. First outbreak of
Tanaka E; Wajima T; Hara N; Shirai A; Shibata M; Shiro H; Noguchi N
J Med Microbiol; 2020 Feb; 69(2):239-243. PubMed ID: 31961789
[No Abstract] [Full Text] [Related]
9. Nationwide survey of the development of drug resistance in the pediatric field in 2007, 2010, and 2012: drug sensitivity of Haemophilus influenzae serotype b strain in Japan.
Baba H; Sato Y; Toyonaga Y; Hanaki H; Sunakawa K
J Infect Chemother; 2015 Apr; 21(4):277-83. PubMed ID: 25618776
[TBL] [Abstract][Full Text] [Related]
10. Nationwide survey of the development of drug resistance in the pediatric field in 2000-2001, 2004, 2007, 2010, and 2012: evaluation of the changes in drug sensitivity of Haemophilus influenzae and patients' background factors.
Shiro H; Sato Y; Toyonaga Y; Hanaki H; Sunakawa K
J Infect Chemother; 2015 Apr; 21(4):247-56. PubMed ID: 25596977
[TBL] [Abstract][Full Text] [Related]
11. Activity of LBM415 compared to those of 11 other agents against Haemophilus species.
Bogdanovich T; Smith KA; Clark C; Pankuch GA; Lin G; McGhee P; Dewasse B; Appelbaum PC
Antimicrob Agents Chemother; 2006 Jul; 50(7):2323-9. PubMed ID: 16801408
[TBL] [Abstract][Full Text] [Related]
12. Rise in Haemophilus influenzae With Reduced Quinolone Susceptibility and Development of a Simple Screening Method.
Seyama S; Wajima T; Yanagisawa Y; Nakaminami H; Ushio M; Fujii T; Noguchi N
Pediatr Infect Dis J; 2017 Mar; 36(3):263-266. PubMed ID: 27870809
[TBL] [Abstract][Full Text] [Related]
13. [Antibacterial susceptibility surveillance of Haemophilus influenzae isolated from pediatric patients in Gifu and Aichi prefectures (2009-2010)].
Takakura M; Fukuda Y; Nomura N; Mitsuyama J; Yamaoka K; Asano Y; Sawamura H; Katsuragawa K; Hashido H; Matsukawa Y; Matsubara S; Oota H; Watanabe K; Yamagishi Y; Mikamo H;
Jpn J Antibiot; 2012 Oct; 65(5):305-21. PubMed ID: 23383433
[TBL] [Abstract][Full Text] [Related]
14. β-Lactamase-non-producing ampicillin-resistant Haemophilus influenzae is acquiring multidrug resistance.
Yamada S; Seyama S; Wajima T; Yuzawa Y; Saito M; Tanaka E; Noguchi N
J Infect Public Health; 2020 Apr; 13(4):497-501. PubMed ID: 31839585
[TBL] [Abstract][Full Text] [Related]
15. influence of TEM-1 beta-lactamase on the pharmacodynamic activity of simulated total versus free-drug serum concentrations of cefditoren (400 milligrams) versus amoxicillin-clavulanic acid (2,000/125 milligrams) against Haemophilus influenzae strains exhibiting an N526K mutation in the ftsI gene.
Torrico M; Aguilar L; González N; Giménez MJ; Echeverría O; Cafini F; Sevillano D; Alou L; Coronel P; Prieto J
Antimicrob Agents Chemother; 2007 Oct; 51(10):3699-706. PubMed ID: 17664320
[TBL] [Abstract][Full Text] [Related]
16. Genetic characteristics and antibiotic resistance of Haemophilus influenzae isolates from pediatric patients with acute otitis media after introduction of 13-valent pneumococcal conjugate vaccine in Japan.
Ubukata K; Morozumi M; Sakuma M; Adachi Y; Mokuno E; Tajima T; Iwata S;
J Infect Chemother; 2019 Sep; 25(9):720-726. PubMed ID: 30987951
[TBL] [Abstract][Full Text] [Related]
17. Activity of nine oral agents against gram-positive and gram-negative bacteria encountered in community-acquired infections: use of pharmacokinetic/pharmacodynamic breakpoints in the comparative assessment of beta-lactam and macrolide antimicrobial agents.
Peric M; Browne FA; Jacobs MR; Appelbaum PC
Clin Ther; 2003 Jan; 25(1):169-77. PubMed ID: 12637118
[TBL] [Abstract][Full Text] [Related]
18. Activity of five quinolones, three macrolides and telithromycin against 12 Haemophilus influenzae strains with different resistance phenotypes.
Pankuch GA; Lin G; Appelbaum PC
Clin Microbiol Infect; 2005 Dec; 11(12):1040-4. PubMed ID: 16307562
[TBL] [Abstract][Full Text] [Related]
19. Are beta-lactam breakpoints adequate to define non-susceptibility for all Haemophilus influenzae resistance phenotypes from a pharmacodynamic point of view?
Alou L; Giménez MJ; Sevillano D; Aguilar L; González N; Echeverría O; Torrico M; Coronel P; Prieto J
J Antimicrob Chemother; 2007 Apr; 59(4):652-7. PubMed ID: 17341471
[TBL] [Abstract][Full Text] [Related]
20. The Association between Transformation Ability and Antimicrobial Resistant Potential in Haemophilus influenzae.
Tanaka E; Wajima T; Ota R; Uchiya KI
Biol Pharm Bull; 2024 Jan; 47(1):154-158. PubMed ID: 37880110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
